Is RX a Buy, Before Earnings?
PremiumPre-EarningsIs RX a Buy, Before Earnings?
1M ago
BioSyent Expands Portfolio with New Endocrinology Product
Premium
Company Announcements
BioSyent Expands Portfolio with New Endocrinology Product
3M ago
BioSyent In-Licenses Endocrinology Product for Canada
Premium
Press Releases
BioSyent In-Licenses Endocrinology Product for Canada
3M ago
BioSyent Declares Second Quarter 2024 Dividend
PremiumPress ReleasesBioSyent Declares Second Quarter 2024 Dividend
4M ago
Biosyent Inc (RX) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Biosyent Inc (RX) Q1 Earnings Cheat Sheet
4M ago
BioSyent Announces Upcoming Q1 2024 Earnings
Premium
Company Announcements
BioSyent Announces Upcoming Q1 2024 Earnings
4M ago
BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement
PremiumPress ReleasesBioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement
5M ago
BioSyent Inc. Spotlights at Investor Conference
Premium
Company Announcements
BioSyent Inc. Spotlights at Investor Conference
5M ago
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Premium
Press Releases
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100